Avicanna Inc. (AVCN.TO)

CAD 0.23

(-4.17%)

Total Liabilities Summary of Avicanna Inc.

  • Avicanna Inc.'s latest annual total liabilities in 2023 was 13.99 Million CAD , down -1.14% from previous year.
  • Avicanna Inc.'s latest quarterly total liabilities in 2024 Q2 was 11.4 Million CAD , down -16.52% from previous quarter.
  • Avicanna Inc. reported annual total liabilities of 14.16 Million CAD in 2022, down -8.01% from previous year.
  • Avicanna Inc. reported annual total liabilities of 15.39 Million CAD in 2021, down -5.25% from previous year.
  • Avicanna Inc. reported quarterly total liabilities of 13.66 Million CAD for 2024 Q1, down -2.39% from previous quarter.
  • Avicanna Inc. reported quarterly total liabilities of 13.99 Million CAD for 2023 Q4, down -29.18% from previous quarter.

Annual Total Liabilities Chart of Avicanna Inc. (2023 - 2016)

Historical Annual Total Liabilities of Avicanna Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 13.99 Million CAD -1.14%
2022 14.16 Million CAD -8.01%
2021 15.39 Million CAD -5.25%
2020 16.24 Million CAD 6.26%
2019 15.28 Million CAD 748.74%
2018 1.8 Million CAD 41.13%
2017 1.27 Million CAD 939.73%
2016 122.76 Thousand CAD 0.0%

Peer Total Liabilities Comparison of Avicanna Inc.

Name Total Liabilities Total Liabilities Difference
Aurora Cannabis Inc. 236.8 Million CAD 94.088%
Avant Brands Inc. 33.22 Million CAD 57.865%
Cardiol Therapeutics Inc. 8.45 Million CAD -65.59%
Crescita Therapeutics Inc. 5.77 Million CAD -142.365%
Knight Therapeutics Inc. 198.62 Million CAD 92.952%
MediPharm Labs Corp. 10.93 Million CAD -28.055%
OrganiGram Holdings Inc. 26.83 Million CAD 47.827%
Canopy Growth Corporation 799.82 Million CAD 98.25%
Willow Biosciences Inc. 3.23 Million CAD -332.468%
Auxly Cannabis Group Inc. 210.85 Million CAD 93.361%